Agios Pharmaceuticals
AGIO
AGIO
212 hedge funds and large institutions have $2.05B invested in Agios Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 87 increasing their positions, 76 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 218 → 212 (-6)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
212
Holding in Top 10
2
Calls
$11.2M
Puts
$8.65M
Top Buyers
| 1 | +$34.6M | |
| 2 | +$21.1M | |
| 3 | +$19.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.1M |
| 5 |
CP
Caligan Partners
New York
|
+$11.2M |
Top Sellers
| 1 | -$29.4M | |
| 2 | -$26.7M | |
| 3 | -$15.1M | |
| 4 |
BlackRock
New York
|
-$8.33M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.12M |